trial · primary record
Cabozantinib
Metastatic Leiomyosarcoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 96 |
| Primary completion | 2027-08-11 |
| Primary endpoint | Progression-free Survival (PFS) |
| Registry ID | NCT04200443 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:43.461Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04200443
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cabozantinib · approval
- Cabozantinib · compound